跳至主要内容
临床试验/NCT06823011
NCT06823011已完成不适用

Effects of Banned Substances on Some Metabolic Functions in Male Amateur Athletes

Hitit University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年6月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
body mass index BMI in Male Athletes

研究概览

简要总结

The aim of this study was to investigate the effects of banned substances on some metabolic functions in male athletes in order to raise awareness among individuals who use these substances by highlighting the potential harms of using banned substances to draw attention to the issue and raise awareness. 2) Methods: The study is a randomised cross-sectional study. The study included 20 male amateur athletes who had actively practised bodybuilding, arm wrestling, powerlifting and weightlifting in the last 5 years and had not participated in competitions. The study group consisted of 10 adult male amateur athletes who had used banned substances at least once a year in the past 5 years, while 10 male amateur athletes who had not used banned substances with similar qualifications formed the control group. Participants were included in the study on a voluntary basis. Participants' age, sports age, height, weight and BMI variables were selected and parameters related to liver, kidney, hormone and lipid profiles were determined. The Shapiro-Wilk test was used to test the normality of the values obtained from the data. The independent t-test was used for the data showing a normal distribution and the Mann Whitney U- test was used for the data not showing a normal distribution.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Amateur athlete who has been actively involved in bodybuilding, arm wrestling, powerlifting and weightlifting for the last 5 years
  • •Adult male amateur athletes who use banned substances in at least 1 period each year

排除标准

  • •with chronic illness
  • •receiving continuous medication
  • •heavy labor
  • •who has recently had an infection
  • •amateur athletes who performed heavy exercise in the last 72 hours

研究组 & 干预措施

group using banned substances

Other

group doing weight training and using banned substances

干预措施: blood collection (Diagnostic Test)

group not using banned substances

Other

a group that does weight training but does not use banned substances

干预措施: blood collection (Diagnostic Test)

结局指标

主要结局

body mass index BMI in Male Athletes

时间窗: 6 months, 1 year

Height, body weight (BW), body mass index \[BMI= BW (kg) / (height, m)2\] were determined.

次要结局

未报告次要终点

研究者

发起方
Hitit University
申办方类型
Other
责任方
Principal Investigator
主要研究者

LEVENT CEYLAN

associate professor

Hitit University

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Significance of Bioactive Substances in Metabolic DiseasesMetabolic diseases
JPRN-UMIN000004192Graduate School of Medicine, Osaka University3,000
已完成
不适用
Influence of Metabolic Profiles on Drug Safety in Routine CareRetinal vascular occlusion, unspecifiedRetinal haemorrhageD50.0Y57.9D62D65.1D68.33D68.35D69.80D69.9G45G95.1H11.3H21.0H31.3H34.0H34.1H34.2H34.8H34.9H35.6H43.1H45.0H92.2I21I22I23I24I25I26I60I61I62I63I64I65I66I71I72I74I79.0I80I81I82I85.0I87.0J94.2K26.0K26.1K26.2K26.4K26.5K26.6K25.0K25.1K25.2K25.4K25.5K25.6K27.0K27.1K27.2K27.4K27.5K27.6K28.0K28.1K28.2K28.4K28.5K28.6K29.0K31.82K55.0K55.1K55.22K57.01K57.03K57.11K57.13K57.21K57.23K57.31K57.33K57.41K57.43K57.51K57.53K57.81K57.83K57.91K57.93K62.5K66.1K76.3K92.0K92.1K92.2M25.0M31.1M62.2N02R04R23.3R31R57.1R58S06.33S06.34S06.4S06.5S06.6S06.8S26.0S27.1S27.31S36.01S36.11S36.81T00.9T45.5T79.2T79.4Y57M60.1M60.8M60.9G72.0M62.8M62.9M79.1M79.7Iron deficiency anaemia secondary to blood loss (chronic)Drug or medicament, unspecifiedAcute posthaemorrhagic anaemiaHaemorrhagic condition, unspecifiedTransient cerebral ischaemic attacks and related syndromesVascular myelopathiesConjunctival haemorrhageHyphaemaChoroidal haemorrhage and ruptureTransient retinal artery occlusionOther retinal artery occlusionsOther retinal vascular occlusionsVitreous haemorrhageVitreous haemorrhage in diseases classified elsewhereOtorrhagiaSubsequent myocardial infarctionCertain current complications following acute myocardial infarctionOther acute ischaemic heart diseasesChronic ischaemic heart diseaseSubarachnoid haemorrhageIntracerebral haemorrhageOther nontraumatic intracranial haemorrhageStroke, not specified as haemorrhage or infarctionOcclusion and stenosis of precerebral arteries, not resulting in cerebral infarctionOcclusion and stenosis of cerebral arteries, not resulting in cerebral infarctionAortic aneurysm and dissectionOther aneurysm and dissectionArterial embolism and thrombosisAneurysm of aorta in diseases classified elsewherePhlebitis and thrombophlebitisOther venous embolism and thrombosisPulmonary embolismPortal vein thrombosisOesophageal varices with bleedingPostthrombotic syndromeHaemothoraxAcute haemorrhagic gastritisAcute vascular disorders of intestineChronic vascular disorders of intestineHaemorrhage of anus and rectumHaemoperitoneumInfarction of liverHaematemesisMelaenaGastrointestinal haemorrhage, unspecifiedHaemarthrosisIschaemic infarction of muscleRecurrent and persistent haematuriaHaemorrhage from respiratory passagesSpontaneous ecchymosesUnspecified haematuriaHypovolaemic shockHaemorrhage, not elsewhere classifiedEpidural haemorrhageTraumatic subdural haemorrhageTraumatic subarachnoid haemorrhageOther intracranial injuriesInjury of heart with haemopericardiumTraumatic haemothoraxMultiple superficial injuries, unspecifiedAnticoagulantsTraumatic secondary and recurrent haemorrhageOther and unspecified drugs and medicamentsInterstitial myositisOther myositisMyositis, unspecifiedDrug-induced myopathyOther specified disorders of muscleDisorder of muscle, unspecifiedMyalgiaTraumatic shockFibromyalgiaCerebral infarctionAcute myocardial infarctionThrombotic microangiopathyCentral retinal artery occlusion
DRKS00013909Bundesinstitut für Arzneimittel und Medizinprodukte10,782
尚未招募
不适用
The alteration of metabolites and clinical correlation in cerebral aneurysm induced subarachnoid hemorrhage patients, a pilot study.Subarachnoid hemorrhage with ruptured intracranial aneurysm and non-ruptured intracranial aneurysmsubarachnoid hemorrhage, ruptured intracranial aneurysm, non-ruptured intracranial aneurysm, TNF-alpha, Metabolites, clinical outcomes
TCTR20211029001RESEARCH ADMINISTRATION DIVISION, KHON KEAN UNIVERSITY32
招募中
不适用
Investigation on the Metabolic Regulation, Anti-inflammatory and Antioxidant Effects of Kaempferia Parviflora Extract to Exercisehealthy individuals
JPRN-UMIN000048305Waseda University30
已完成
不适用
Investigation of the metabolism and toxicokinetics of the surfactant 2,4,7,9-tetramethyl-5-decyne-4,7-diol (TMDD) in humansExposition of humans with TMDD
DRKS00022825Verband der Chemischen Industrie e.V.4